This company listing is no longer active
Algorae Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Algorae Pharmaceuticals has a total shareholder equity of A$3.6M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$3.8M and A$140.2K respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$3.62m |
| Equity | AU$3.62m |
| Total liabilities | AU$140.16k |
| Total assets | AU$3.76m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LHI1's short term assets (A$3.8M) exceed its short term liabilities (A$140.2K).
Long Term Liabilities: LHI1 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: LHI1 is debt free.
Reducing Debt: LHI1 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LHI1 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LHI1 has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 10.4% each year.